By Conjoint Professor David goldstein

Journal articles

Taggart J; Chin M; Liauw W; Goldstein D; Uebel K; Vuong K; Mendoza-Jones P; Harris MF, 2026, 'Feasibility study of a colorectal cancer e-care plan for shared follow-up survivorship care', Australian Journal of Primary Health, 32, pp. PY25068, http://dx.doi.org/10.1071/PY25068

Sharbeen G; Kokkinos J; Schulstad G; Pandzic E; Youkhana J; Ma Z; Ignacio RMC; Raina AS; Chiang S; Boyer C; Haghighi KS; Gunawarman M; Goldstein D; Gebski V; Pajic M; Davis ME; Arkell OSM; Kopecky C; Gonzales-Aloy E; Ishak A; Erkan M; Morton JP; Kavallaris M; Gunning PW; Hardeman EC; Johns A; Gill AJ; Whan RM; Mawson A; Pitiyarachchi O; Australian Pancreatic Cancer Genome Initiative ; McCarroll JA; Phillips PA, 2026, 'βIII-tubulin can act as a brake on extrinsic apoptosis in pancreatic cancer.', Cell Death Dis, http://dx.doi.org/10.1038/s41419-026-08657-6

Best MC; Descallar J; Simpson G; Napier CE; Bartley N; Ballinger ML; Goldstein D; Thomas DM; Tucker KM; Butow P, 2026, 'Impact of Spiritual Wellbeing in Advanced Cancer Patients Receiving Genomic Test Results', Psycho Oncology, 35, http://dx.doi.org/10.1002/pon.70471

Koh B; Thavaneswaran S; Lin F; Grady J; Maddula M; Haghighi KS; Kansara M; Huang ML; Ballinger ML; Simes J; Thomas DM; Goldstein D, 2026, 'Exceptional Response to Durvalumab and Tremelimumab in Pancreatic Acinar Cell Carcinoma With Ultramutated Phenotype Associated With a DNA Polymerase-ε Mutation', JCO Precision Oncology, 10, http://dx.doi.org/10.1200/PO-25-01003

Chiang JCB; Makrynioti D; Goldstein D; Naduvilath TJ; Trinh T; O’Neill S; Hovey E; Lewis CR; Friedlander M; Au K; Alotaibi S; Park SB; Markoulli M; Krishnan AV, 2026, 'Dose-dependent neurotoxic chemotherapy and corneal nerve morphological changes', Clinical and Experimental Optometry, http://dx.doi.org/10.1080/08164622.2025.2606161

Lin FP; Thavaneswaran S; Grady JP; Napier CE; Kansara M; Sebastian L; Kee D; Desai J; Zaheed M; Chinchen S; Oakes SR; Blackburn J; Scott HS; Glover A; Fox SB; Goldstein D; Leo P; Amanuel B; Mersiades A; Millward M; Brown MP; Charakidis M; Pokorny AMJ; Craft P; Espinoza D; Grimison P; Harrup R; Joshua AM; O’Byrne K; Lee CK; Cowley MJ; Ballinger ML; Simes J; Thomas DM, 2026, 'Genomic Therapy Matching in Rare and Refractory Cancers', JAMA Oncology, http://dx.doi.org/10.1001/jamaoncol.2026.0127

Zahid Hosen SM; Kumar AA; Xu Z; Mekapogu AR; Perera C; Pang T; Pirola R; Wilson J; Goldstein D; Buckley BJ; Kelso MJ; Ranson M; Apte M, 2026, 'Selective Urokinase Inhibition Plus Chemotherapy: A Novel Approach to Pancreatic Cancer Treatment via Enhanced Antitumor Immunity and Decreased Metastasis', Gastroenterology, 170, pp. 89 - 105, http://dx.doi.org/10.1053/j.gastro.2025.07.021

Lee S; McIntyre J; Robertson T; Kallsen K; Bauer M; Berardi R; Boisvert-Huneault C; Clerisme-Beaty E; Denton CP; Fakra E; Geissler J; Goldstein D; Hasegawa K; Lind M; LoRusso P; Perry K; Röhl C; Saraiva JFK; Swarup N; Szpisjak A; Flyvbjerg A, 2026, 'Shaping the future of clinical trials through strategic foresight', Clinical Trials, http://dx.doi.org/10.1177/17407745251414680

Stutheit-Zhao EY; Sr RRS; Baskurt Z; Rostami A; Zhao Z; Zou J; Penny L; Collier E; Kotlarz K; Huang SH; Tadic T; Xu W; Hope AJ; Tsai CJ; Goldstein D; Garcia ES; Liu G; O'Sullivan B; Waldron JN; Bratman SV, 2026, 'High-Sensitivity HPV Circulating Tumor DNA (ctDNA) Outperforms Conventional Imaging for Immediate Post-Treatment Risk Stratification in Oropharyngeal Cancer', International Journal of Radiation Oncology*Biology*Physics, 125, pp. e81 - e81, http://dx.doi.org/10.1016/j.ijrobp.2026.02.163

Chiang S; Garcia Netto K; Kokkinos J; Haghighi KS; Raina AS; Youkhana J; Pitiyarachchi O; Truong Q; Wenholz D; Wilkinson J; Laczka O; Li X; Aldilla VR; Kumar N; Goldstein D; Sharbeen G; Phillips PA, 2025, 'CRO-67 has anti-cancer activity in pancreatic tumor cells and stromal cancer-associated fibroblasts', Scientific Reports, 15, http://dx.doi.org/10.1038/s41598-025-09411-2

Liang S; Kennedy E; Gale N; Watson P; Ramanathan M; Shinde A; McKay S; Torres-Robles A; Li Z; Chan J; Jones H; Ballinger ML; Butow P; Goldstein D; Leaney K; Middleton S; Morrow A; Thomas DM; Tucker KM; Zaheed M; Parkinson B; Lin F; Taylor N; Torres Robles A, 2025, 'Implementation of precision medicine in treating non-communicable diseases: a systematic review', Journal of Translational Medicine, 23, pp. 1174, http://dx.doi.org/10.1186/s12967-025-07201-y

Maharaj AD; Brown B; Evans H; Evans SM; Ioannou LJ; Earnest A; Croagh D; Pilgrim CHC; Greenhill E; Neale RE; Goldstein D; Kench JG; Merrett ND; White K; Haghighi KS; Samra JS; Zalcberg JR, 2025, 'Aiming for high quality of care for completed resections and improved margin status in pancreatic cancer surgery', Pancreatology, 25, pp. 1192 - 1199, http://dx.doi.org/10.1016/j.pan.2025.09.029

Naher SK; Espinoza D; Grimison P; Shitara K; Pavlakis N; Goldstein D; Stockler MR; Mercieca-Bebber R; Sjoquist KM, 2025, 'Development and validation of a prognostic model incorporating patient reported outcomes for advanced gastric and esophageal carcinoma (AGOC) using individual patient data from two AGITG randomized clinical trials', Gastric Cancer, 28, pp. 1241 - 1251, http://dx.doi.org/10.1007/s10120-025-01654-2

Martin AJ; Soon YY; Sjoquist KM; Pavlakis N; Goldstein D; Shitara K; Simes JR, 2025, 'Health-related quality-of-life outcomes with regorafenib in advanced gastric and esophagogastric junction cancer: results from the INTEGRATE trials', Gastric Cancer, 28, pp. 1252 - 1259, http://dx.doi.org/10.1007/s10120-025-01670-2

Hayat F; Chiu S; Stuart A; Lee B; Gibbs P; Johns J; Thomson B; Wong R; Lee M; Nikfarjam M; Shapiro J; McLachlan SA; Chee CE; Zielinski R; Tai D; Pattison S; Caird S; Wong ZW; Cooray P; Underhill C; Roy A; Nagrial A; Goldstein D; Paul C; Day F, 2025, 'Effects of current smoking on treatment outcomes in metastatic and locally advanced pancreatic carcinoma: a retrospective cohort study using the international PURPLE pancreas cancer registry', Journal of Gastrointestinal Oncology, 16, pp. 2377 - 2387, http://dx.doi.org/10.21037/jgo-2025-186

Liang S; McKay S; Lin F; Zaheed M; Morrow A; Douglas B; Chan J; Monaghan H; Chan P; Kennedy E; Tyedmers E; Walker S; Leaney K; Napier CE; Middleton S; Butow P; Williams R; Parkinson B; Ballinger ML; Tucker K; Goldstein D; Thomas D; Taylor N, 2025, 'Integration of precision medicine into routine cancer care—protocol for the Precision Care Initiative: a research programme of effectiveness-implementation hybrid trials', BMJ Open, 15, http://dx.doi.org/10.1136/bmjopen-2024-090270

Sharbeen G; Youkhana J; Netto KG; Raina AS; Chiang S; Haghighi KS; Kokkinos J; Pitiyarachchi O; Yang J; Wang T; Swarbrick A; Goldstein D; Phillips PA, 2025, 'Assessing the response of 3D human pancreatic tumor explants to standard chemotherapy', CANCER RESEARCH, 85, pp. B80 - B80, http://dx.doi.org/10.1158/1538-7445.PANCREATIC25-B080

Schulstad G; Kokkinos J; Youkhana J; Raina AS; Davis ME; Arkell OSM; Netto KG; Boyer C; Goldstein D; Haghighi KS; Sharbeen G; McCarroll JA; Phillips PA, 2025, 'βIII-tubulin is a dual cell therapeutic target in pancreatic cancer and regulates sensitivity to TRAIL through a DR5-dependent mechanism', CANCER RESEARCH, 85, pp. A67 - A67, http://dx.doi.org/10.1158/1538-7445.PANCREATIC25-A067

Lui RN; Billod J; Frentzas S; Hoang H; Eaton V; Lei XJ; Garrett-Mayer E; Goldstein D; Dent R; Chua MLK, 2025, 'Understanding Barriers to Clinical Cancer Research in the Asia-Pacific', JCO Global Oncology, 11, http://dx.doi.org/10.1200/GO-25-00145

Michael M; Wong R; Gill S; Strickland AH; Pavlakis N; Shapiro JD; Link E; Farrell M; Ngan SY; Tie J; Heriot AG; Goldstein D; Mitchell C; Roth S; Wilson K; Mui M; Ramsay RG; Segelov E, 2025, 'The Ave–Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer', Clinical Cancer Research, 31, pp. 3452 - 3462, http://dx.doi.org/10.1158/1078-0432.CCR-25-0705

Soon YY; Sjoquist K; Marschner IC; Schou IM; Pavlakis N; Goldstein D; Shitara K; Stockler MR; Simes J; Martin AJ, 2025, 'INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner's curse', Jnci Cancer Spectrum, 9, http://dx.doi.org/10.1093/jncics/pkaf053

Heinrich MC; Blay JY; Gelderblom H; George S; Schöffski P; von Mehren M; Zalcberg JR; Jones RL; Kang YK; Razak AA; Trent J; Attia S; Le Cesne A; Boye K; Goldstein D; Sánchez C; Siontis BL; Cox P; Davis E; Sherman ML; Ruiz-Soto R; Bauer S, 2025, 'Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE', Journal of Clinical Oncology, 43, pp. 2239 - 2244, http://dx.doi.org/10.1200/JCO-24-02818

Lin FP-Y; Goldstein D; Grady JP; Napier C; Thavaneswaran S; Pitiyarachchi O; Kansara M; Chantrill LA; Sjoquist K; Thornton K; Raina A; Magenau A; Simes J; Ballinger ML; Sharbeen G; Timpson P; Pajic M; Phillips P; Thomas DM, 2025, 'Genomic and outcome analysis of recurrent versus de novo metastatic pancreatic ductal adenocarcinoma (PDAC) receiving systemic therapy: Results from the Australian MoST and CaSP screening programs.', JOURNAL OF CLINICAL ONCOLOGY, 43, pp. 4120 - 4120, http://dx.doi.org/10.1200/JCO.2025.43.16_suppl.4120

Sousa MS; Garcia MV; Blanchard M; Daveson B; Currow D; Khan NN; Goldstein D; Findlay M; Landers A; Agar MR, 2025, 'Navigating pain and appetite challenges in palliative care for pancreatic cancer: insights from a national, longitudinal consecutive cohort study', Supportive Care in Cancer, 33, http://dx.doi.org/10.1007/s00520-025-09402-z

Ephraums J; Youkhana J; Raina AS; Schulstad G; Croft K; Mawson A; Kokkinos J; Gonzales-Aloy E; Ignacio RMC; McCarroll JA; Boyer C; Goldstein D; Pajic M; Haghighi KS; Johns A; Gill AJ; Erkan M; Initiative (APGI) APCG; Phillips PA; Sharbeen G, 2025, 'MYH knockdown in pancreatic cancer cells creates an exploitable DNA repair vulnerability', Neoplasia United States, 61, http://dx.doi.org/10.1016/j.neo.2025.101138

Biesma NC; Graus MUJE; Cirkel GA; Besselink MG; de Groot JWB; Koerkamp BG; Herbschleb KH; Los M; Verdonk RC; Wilmink JW; Cervantes A; Valle JW; Valkenburg-van Iersel LBJ; Froeling FEM; Molenaar IQ; Daamen LA; de Vos-Geelen J; van Santvoort HC; Bockorny B; Carrato A; Chen L; Coveler AL; Dajani O; Diaz LA; El-Rayes BF; Goldstein D; Halfdanarson TR; Hosein PJ; Kim EJ; Liang T; Melisi D; Pruijt JFM; Santoro A; Verschoor AJ; van Voorthuizen T, 2025, 'Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer: An international expert survey and case vignette study', European Journal of Surgical Oncology, 51, http://dx.doi.org/10.1016/j.ejso.2024.109544

Bonazzi VF; Aoude LG; Brosda S; Bradford JJ; Lonie JM; Loffler KA; Gartside MG; Patel K; Mukhopadhyay P; Keane C; Gebski V; Kench JG; Goldstein D; Waddell N; Barbour AP, 2025, 'C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients', Asia Pacific Journal of Clinical Oncology, 21, pp. 77 - 86, http://dx.doi.org/10.1111/ajco.13993

Pavlakis N; Shitara K; Sjoquist K; Martin A; Jaworski A; Tebbutt N; Bang YJ; Alcindor T; O'Callaghan C; Strickland A; Rha SY; Lee KW; Kim JS; Bai LY; Hara H; Oh DY; Yip S; Zalcberg J; Price T; Simes J; Goldstein D, 2025, 'INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer', Journal of Clinical Oncology, 43, pp. 453 - 463, http://dx.doi.org/10.1200/JCO.24.00055

Trinh T; Au K; Krishnan AV; Timmins HC; Li T; Grimison P; Goldstein D; Park SB, 2025, 'Comparison of nab-paclitaxel, paclitaxel, and oxaliplatin-induced peripheral neuropathy: a cross-sectional cohort study', Acta Oncologica, 64, pp. 527 - 533, http://dx.doi.org/10.2340/1651-226X.2025.42935

Li T; Goldstein D; Park SB, 2025, 'What you measure matters: The importance of outcome measures in evaluating the prevalence of painful chemotherapy-induced peripheral neuropathy', Regional Anesthesia and Pain Medicine, http://dx.doi.org/10.1136/rapm-2025-106586

Naher SK; Espinoza D; Grimison PS; Shitara K; Pavlakis N; Goldstein D; Stockler MR; Mercieca-Bebber R; Sjoquist K, 2025, 'Development and validation of a prognostic model for advanced gastric and oesophageal carcinoma (AGOC) using individual patient data from two clinical trials.', JOURNAL OF CLINICAL ONCOLOGY, 43, pp. 499 - 499, http://dx.doi.org/10.1200/JCO.2025.43.4_suppl.499

Makrynioti D; Bo Chiang JC; Goldstein D; Naduvilath T; Trinh T; O’Neill S; Hovey E; Lewis C; Friedlander M; Au K; Alotaibi S; Park SB; Markoulli M, 2025, 'Dose-dependent corneal nerve morphological changes due to neurotoxic chemotherapy: an in vivo corneal confocal microscopy study', Contact Lens and Anterior Eye, 48, pp. 102557 - 102557, http://dx.doi.org/10.1016/j.clae.2025.102557

Joda M; Li T; Timmins HC; Goldstein D; Kiernan MC; Park SB, 2025, 'Identification of axonal degeneration in paclitaxel-treated patients utilising neurophysiological and blood based biomarkers', Clinical Neurophysiology, 176, pp. 2110928 - 2110928, http://dx.doi.org/10.1016/j.clinph.2025.2110928

Lin FP; McKay S; Zaheed M; Douglas B; Ke H; Koh B; Liang S; Morrow A; Chan J; Chua B; Kennedy E; Leaney K; Monaghan H; Middleton S; Ballinger ML; Thomas DM; Parkinson B; Tucker K; Goldstein D; Taylor N, 2025, 'Impact of a quaternary genomics multidisciplinary team (MDT) on oncological decision-making: Pilot phase of the UNSW precision care initiative (PCI)', ANNALS OF ONCOLOGY, 36, http://dx.doi.org/10.1016/j.annonc.2025.10.1195

Goldstein D; Sjoquist K; Espinosa D; Rha SY; Goetze TO; Tebbutt N; Hara H; Lee K-W; Ryu MH; Goekkurt E; Thuss-Patience PC; Haag GM; Lorenzen S; Simes J; Karapetis CS; Price TJ; Siu D; Moehler M; Shitara K; Pavlakis N, 2025, 'LBA80 Regorafenib plus nivolumab vs investigator’s choice of chemotherapy in previously treated gastric or gastroesophageal cancer: INTEGRATE IIb, a randomized phase 3 AGITG Intergroup [NHMRC-CTC/IKF/AIO, ACCRU, TCOG/NHRI] study', Annals of Oncology, 36, pp. S1622 - S1623, http://dx.doi.org/10.1016/j.annonc.2025.09.095

Liang S; Lin FP; Mckay S; Fox S; Millward M; Kichenadasse G; Lau L; Lane SW; Gan HK; Leo P; Lawrence B; Scott CL; Kee D; Zaheed M; Middleton S; Parkinson B; Ballinger ML; Thomas DM; Goldstein D; Taylor N, 2025, 'Operational challenges of molecular tumour board (MTBs) in the Australasian public healthcare services: A scoping survey to inform the future of precision oncology', ANNALS OF ONCOLOGY, 36, http://dx.doi.org/10.1016/j.annonc.2025.10.1183

Li T; Timmins HC; Horvath LG; Harrison M; Grimison P; Friedlander M; Marx G; Boyle F; Wyld D; Henderson R; King T; Baron-Hay S; Kiernan MC; Barnes EH; Goldstein D; Park SB, 2025, 'Risk factors for dose-limiting, chronic and severe chemotherapy-induced peripheral neuropathy', Clinical Neurophysiology, 176, pp. 2110921 - 2110921, http://dx.doi.org/10.1016/j.clinph.2025.2110921

Tzelnick S; de Almeida JR; Yao CMKL; Kibel S; Kuehne N; Grewal R; Butler MO; Saibil S; Spreafico A; Easson A; Goldstein DP, 2024, 'Nodal Metastases in Stage 3 Head and Neck Melanoma: Patterns of Metastases and Patterns of Failure', Laryngoscope, 134, pp. 4292 - 4297, http://dx.doi.org/10.1002/lary.31515

Best MC; Butow P; Savard J; Newson AJ; Campbell R; Vatter S; Napier CE; Bartley N; Tucker K; Ballinger ML; Thomas DM; Best MC; Butow P; Newson AJ; Juraskova I; Schlub T; Davies G; Meiser B; Goldstein D, 2024, 'From ownership to custodianship of tumor biopsy tissue in genomic testing: A mixed methods study of patient views', Oncologist, 29, pp. e1169 - e1179, http://dx.doi.org/10.1093/oncolo/oyae074

Li T; Timmins HC; Mahfouz FM; Trinh T; Mizrahi D; Horvath LG; Harrison M; Grimison P; Friedlander M; Marx G; Boyle F; Wyld D; Henderson R; King T; Baron-Hay S; Kiernan MC; Rutherford C; Goldstein D; Park SB, 2024, 'Validity of Patient-Reported Outcome Measures in Evaluating Nerve Damage Following Chemotherapy', JAMA Network Open, 7, pp. e2424139, http://dx.doi.org/10.1001/jamanetworkopen.2024.24139

Niederberger M; Schifano J; Deckert S; Hirt J; Homberg A; Köberich S; Kuhn R; Rommel A; Sonnberger M; Alam M; Backman C; Banno M; Bartoszko J; Bloomfield F; Bober MB; Chalkoo M; Chan TM; Chen Y; Coscia C; de Luca K; Demartines N; Farzandipour M; Goldstein D; Goodman C; Grant S; Hübner M; Harris T; Howell M; Huber AM; Jansen TL; Johnson N; Julious SA; Kenny GP; Konge L; Kopkow C; LaPrade RF; Lim M; Loudovici-Krug D; Ma Y; MacLennan S; Mokkink LB; Montero M; Myles PS; Nayahangan LJ; Pace NL; Page MJ; Parente F; Payne K; Petrovic M; Sprung CL; Raveendran K; Roller-Wirnsberger R; Sconfienza LM; Spinelli A; van der Heijde D; Vohra S; Weissman JS; Westby M; Wu Y; Yadlapati R; Yarris LM; Zhang X, 2024, 'Delphi studies in social and health sciences—Recommendations for an interdisciplinary standardized reporting (DELPHISTAR). Results of a Delphi study', Plos One, 19, http://dx.doi.org/10.1371/journal.pone.0304651

De Almeida JR; Martino R; Hosni A; Goldstein DP; Bratman SV; Chepeha DB; Waldron JN; Weinreb I; Perez-Ordonez B; Yu E; Metser U; Hansen AR; Xu W; Su SJ; Kim J, 2024, 'Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial', JAMA Otolaryngology Head and Neck Surgery, 150, pp. 463 - 471, http://dx.doi.org/10.1001/jamaoto.2024.0423

Li T; Timmins HC; Mahfouz FM; Mizrahi D; Horvath L; Harrison ML; Grimison PS; Friedlander M; Marx GM; Boyle FM; Wyld D; Henderson R; King T; Baron-Hay SE; Kiernan MC; Rutherford C; Goldstein D; Park SB, 2024, 'Identifying optimized assessment of nerve damage during chemotherapy.', Journal of Clinical Oncology, 42, pp. 12016 - 12016, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.12016

Li T; Trinh T; Bosco A; Kiernan MC; Goldstein D; Park SB, 2024, 'Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes', Supportive Care in Cancer, 32, http://dx.doi.org/10.1007/s00520-024-08484-5

Yeung N; Li T; Lin HM; Timmins HC; Goldstein D; Harrison M; Friedlander M; Mahon KL; Giles C; Meikle PJ; Park SB; Horvath LG, 2024, 'Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy', JCO Precision Oncology, 8, http://dx.doi.org/10.1200/PO.23.00690

Mahfouz FM; Li T; Timmins HC; Horvath LG; Harrison M; Grimison P; Marx G; Goldstein D; Park SB, 2024, 'Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity', Jnccn Journal of the National Comprehensive Cancer Network, 22, pp. 108 - 116, http://dx.doi.org/10.6004/jnccn.2023.7083

Mahfouz FM; Li T; Joda M; Harrison M; Kumar S; Horvath LG; Grimison P; King T; Goldstein D; Park SB, 2024, 'Upper-limb dysfunction in cancer survivors with chemotherapy-induced peripheral neurotoxicity', Journal of the Neurological Sciences, 457, http://dx.doi.org/10.1016/j.jns.2023.122862

Heinrich MC; Jones RL; George S; Gelderblom H; Schöffski P; von Mehren M; Zalcberg JR; Kang YK; Razak AA; Trent J; Attia S; Le Cesne A; Siontis BL; Goldstein D; Boye K; Sanchez C; Steeghs N; Rutkowski P; Druta M; Serrano C; Somaiah N; Chi P; Reichmann W; Sprott K; Achour H; Sherman ML; Ruiz-Soto R; Blay JY; Bauer S, 2024, 'Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial', Nature Medicine, 30, pp. 498 - 506, http://dx.doi.org/10.1038/s41591-023-02734-5

Mahfouz FM; Li T; Joda M; Harrison M; Horvath LG; Grimison P; King T; Marx G; Goldstein D; Park SB, 2024, 'Sleep dysfunction associated with worse chemotherapy-induced peripheral neurotoxicity functional outcomes', Supportive Care in Cancer, 32, http://dx.doi.org/10.1007/s00520-023-08245-w

Zhang BYH; Georgiou C; Turner C; Kee D; Goldstein D; Haurat J; Bourne A; Turner M; Scott CL, 2024, '39O Four years and 1400+ patient referrals: Achievements of the Australian Rare Cancer Portal', ESMO Open, 9, pp. 102428 - 102428, http://dx.doi.org/10.1016/j.esmoop.2024.102428

Back to profile page